Last update 16 Jul 2025

NeoDC vaccine(Sichuan University)

Overview

Basic Info

Drug Type
Therapeutic vaccine, Dendritic cell vaccine
Synonyms
Neo-DCVac, neoantigen-primed dendritic cell (DC) cell vaccine, personal neoantigen-sensitized DC(NeoDC) vaccine
+ [1]
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsDigestive System DisordersRespiratory Diseases
Active Indication
Colorectal CancerHepatocellular CarcinomaNon-Small Cell Lung Cancer+ [1]
Inactive Indication
Esophageal Squamous Cell Carcinoma
Originator Organization
Sichuan UniversitySichuan University
Active Organization
Sichuan UniversitySichuan University
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with NeoDC vaccine(Sichuan University)
NCT06329908
/ RecruitingEarly Phase 1IIT
Single-arm, Open, Prospective Clinical Study of Neoantigen-loaded Dendritic Cell Vaccine (Neo-DCVac) Combined With Immune Checkpoint Inhibitors (ICIs) in the Treatment of Advanced Lung Cancer Resistant to ICIs
NCT05317325
/ Unknown statusPhase 1IIT
A Translational Study of Tumor Antigen-pulsed Dendritic Cell Vaccine for Esophageal Squamous Cell Carcinoma
NCT04147078
/ RecruitingPhase 1IIT
Adjuvant Treatment in Cancer Patients with Neoantigen-primed DC Vaccine : a Single-arm, Open-label, Prospective Clinical Trial
100 Clinical Results associated with NeoDC vaccine(Sichuan University)
Login to view more data
100 Translational Medicine associated with NeoDC vaccine(Sichuan University)
Login to view more data
100 Patents (Medical) associated with NeoDC vaccine(Sichuan University)
Login to view more data
100 Deals associated with NeoDC vaccine(Sichuan University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Esophageal Squamous Cell CarcinomaPhase 1
China
Sichuan UniversitySichuan University
01 Apr 2022
Colorectal CancerPhase 1
China
Sichuan UniversitySichuan University
01 Jun 2019
Hepatocellular CarcinomaPhase 1
China
Sichuan UniversitySichuan University
01 Jun 2019
Non-Small Cell Lung CancerPhase 1
China
Sichuan UniversitySichuan University
01 Jun 2019
Stomach CancerPhase 1
China
Sichuan UniversitySichuan University
01 Jun 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free